| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer,Svp-r& D | Chief Scientific Officer,Svp-r& D | Sr Vp-research & Development +1 more
1 company
Frederique Ph.D. Menzaghi last filed a Form 4 in February 2024, as Chief Scientific Officer,Svp-r& D at TVRD. From March 2015 to February 2024, the filings on record show 0 open-market purchases and 45 sales. Frederique Ph.D. Menzaghi's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Frederique Ph.D. Menzaghi a strong insider score of 85/100, based on 7 past trades. Over a 12-month horizon, all 7 of those trades were profitable, with an average 12-month return of +64.8%.
At the last filing, the largest reported position was 167,247 shares of TVRD. The TVRD filings lean toward selling, a net 283,239 shares.
Shares as reported in the last Form 4 for each company; the most recent is from February 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2019 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Officer,Svp-r& D | Sell | 20,000 | $18.65 | $373,020.11 | -14.0% | |
| Feb 28, 2019 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 1,500 | $17.50 | $26,250.00 | -1.0% | |
| Feb 25, 2019 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 2,200 | $17.50 | $38,500.00 | -1.5% | |
| Dec 28, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 4,300 | $12.53 | $53,879.00 | -2.9% | |
| Dec 3, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 3,000 | $18.36 | $55,080.00 | -2.1% | |
| Nov 1, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sale+OE | 3,000 | $18.77 | $56,310.00 | -2.1% | |
| Oct 1, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 3,000 | $23.99 | $71,970.00 | -3.1% | |
| Sep 4, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 3,000 | $19.81 | $59,430.00 | -3.0% | |
| Aug 20, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 3,000 | $18.89 | $56,670.00 | -2.9% | |
| Jul 2, 2018 | TVRD Tvardi Therapeutics, Inc. | Sr Vp-research & Development | Sell | 3,000 | $19.00 | $57,000.00 | -2.8% |